← FDA Drug Approvals (Drugs@FDA)

ATORVASTATIN CALCIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS INC · Approved 2025-11-13

Drug application

FDA Application #

ANDA220276

Application type

Abbreviated New Drug Application (Generic)

Brand name

ATORVASTATIN CALCIUM

Generic name

ATORVASTATIN CALCIUM

Active ingredients

ATORVASTATIN CALCIUM

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

TEVA PHARMS INC

Manufacturer

Teva Pharmaceuticals, Inc.

First approval

2025-11-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown